NEW YORK (GenomeWeb News) – Laboratory Corporation of America is offering Roche's new Cobas AmpliPrep/Cobas TaqMan HCV test, which the US Food and Drug Administration cleared for marketing in October 2008.

The test is fully automated and uses Roche's proprietary real-time PCR technology to quantify the amount of virus in an individual's blood. Physicians can use it to monitor viral load at baseline and during treatment to help determine the effectiveness of therapy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.